Offer An Article

Pandemic Latest News

Takeda

Genetic editing, the answer to bad cholesterol? The latest health stories from around the world

A technique for precisely rewriting the genetic code directly in the body has slashed “bad” cholesterol levels—possibly for life—in three people prone to dangerously high levels of the artery-clogging fat. The feat relied on a blood infusion of a so-called base editor, designed to disable a liver protein, PCSK9, that regulates cholesterol. https://www.science.org/content/article/base-editing-a-new-form-of-gene-therapy-sharply-lowers-bad-cholesterol?  “It is […]

Genetic editing, the answer to bad cholesterol? The latest health stories from around the world Read More »

Rare disease diagnosis programme unveiled by Takeda

An Indian company, part of a broader group of firms under the Takeda, banner has announced a new diagnostics programme aimed towards rare diseases. The “ILLUMINATE” programme, independently run and managed by PerkinElmer and sponsored by Baxalta Bioscience India, aims to improve diagnosis rates of patients with Lysosomal Storage Disorders (LSD).   Raredisease.org defines LSDs

Rare disease diagnosis programme unveiled by Takeda Read More »